FDA.reportPublic FDA data

Motto

Manufacturer
Motto-Elektro Ltd.
Effective date
2013-02-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:34:49

Label at a glance#

ProductMotto
Active ingredientSULFUR
Label structure9 sections

Dosage and administration

Clean the affected area. Remove the silikon paper film from the patch.

Label contents#

Full prescribing information#

Purpose

OTC - PURPOSE SECTION

external analgesic

Uses

Releives chronic and acute pain of muscles and joints due to:

  • rheumatic complaints
  • lumbago
  • headache
  • tennis elbow
  • menstrual pain

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

sulfur 9 mg

Warnings

WARNINGS SECTION

For external use only

If pregnant or breast-feeding, ask a health professional before use

Allergy alert:

This product contains natural rubber latex which may cause allergic reactions.

Do not use

  • on wounds
  • on irritated or damaged skin
  • with a heating pad
  • otherwise than as directed

Stop use and ask a doctor if

  • excessive irritation of the skin develops
  • condition worsens
  • skin rush occurs

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

to avoid accidental poisoning. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

INDICATIONS & USAGE SECTION

Clean the affected area. Remove the silikon paper film from the patch.

Dosage

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years of age and older: cut up a patch into pieces of desired sizes and apply to affected area. Use up to 10 days.
  • children under 12 years of age: do not use, consult your physician
  • use according to the User Guide inside the package
  • refer to the above warnings; use otherwise than as directed may be dangerous

Other information

Store at room temperature 15° to 30°C (59° to 86°F), away from sunlight.

Inactive ingredient

INACTIVE INGREDIENT SECTION

zinc oxide, on an adhesive bandage backing with a protective paper

Questions or Comments?

OTC - QUESTIONS SECTION

Ph. 1-888-477-5374 M-F 9 am to 5 pm

You may also report serious side effects to this phone number.

Motto analgesic patch package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

analgesic_package.jpganalgesic_package.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53093-433-472019-11-27C16284748780-19855d018-e36c-cd31-e053-dbdaa90ab51a3a6d1c1d-49dd-438f-821e-8c885e9cbfcf

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53093-433-47Motto9 mg in 1 PATCHPATCH91
53093-433-47Motto2 in 1 PACKAGEPATCH21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53093-433MOTTO (SULFUR) PATCH [MOTTO-ELEKTRO LTD.]1Legacy NDC, 2 package rows20130310_3a6d1c1d-49dd-438f-821e-8c885e9cbfcf.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SULFURACTIVE INGREDIENT70FD1KFU701
SULFURACTIVE MOIETY70FD1KFU701
ZINC OXIDEINACTIVE INGREDIENTSOI2LOH54Z1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53093-43353093-433-47

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
SULFUR70FD1KFU70ACTIB
ZINC OXIDESOI2LOH54ZIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 6 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ZINC OXIDEZINC OXIDESOI2LOH54ZSUPPOSITORY / RECTAL375 mgExact identifier — unii candidate
6 equally ranked IID candidates
ZINC OXIDEZINC OXIDESOI2LOH54ZSOLUTION / RESPIRATORY (INHALATION)3.11 %w/vExact identifier — unii candidate
6 equally ranked IID candidates
ZINC OXIDEZINC OXIDESOI2LOH54ZSOLUTION / INTRAVENOUS3.11 %w/vExact identifier — unii candidate
6 equally ranked IID candidates
ZINC OXIDEZINC OXIDESOI2LOH54ZINJECTION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
6 equally ranked IID candidates
ZINC OXIDEZINC OXIDESOI2LOH54ZLOTION / TOPICAL16 %w/wExact identifier — unii candidate
6 equally ranked IID candidates
ZINC OXIDEZINC OXIDESOI2LOH54ZINJECTION, SUSPENSION / SUBCUTANEOUSNAExact identifier — unii candidate
6 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
59295ea1-e6a6-42df-8716-b25605d52a693a6d1c1d-49dd-438f-821e-8c885e9cbfcf2013-02-26WarningsExact identifier
spl id: 59295ea1-e6a6-42df-8716-b25605d52a69
spl set id: 3a6d1c1d-49dd-438f-821e-8c885e9cbfcf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.